Target intelligence / Profile preview

B-cell receptor idiotype (Id (idiotype))

Target
Id (idiotype)
Molecular classification
Other (antigenic determinant on the variable region of the B-cell receptor/immunoglobulin, not a distinct gene-encoded receptor protein), Receptor-associated determinant (present on the B-cell receptor complex via its variable regions)
01

Overview

The B-cell receptor idiotype refers to the unique antigenic determinants located in the variable regions of an individual B cell’s immunoglobulin/B-cell receptor; these idiotypic determinants (Ids) arise from somatic V(D)J recombination and define the clonotypic specificity of the BCR. The B-cell receptor itself is a membrane immunoglobulin (isotypes IgM/IgD/IgG/IgA/IgE) noncovalently associated with the Igα/Igβ (CD79A/CD79B) signaling heterodimer bearing ITAMs that initiate signaling upon antigen binding. Idiotypes are immunogenic and can elicit anti-idiotype immune responses; B cells can present idiotype-derived peptides via MHC class II to T cells, integrating idiotype/anti-idiotype interactions into immune regulation and memory. Clinically, the tumor-specific BCR idiotype of clonal B-cell malignancies has been exploited as a therapeutic target using anti-idiotype monoclonal antibodies and patient-specific idiotype vaccines, and as a sensitive biomarker for disease monitoring.

Other names
idiotypeBCR idiotypeimmunoglobulin idiotypeantibody idiotypeB-cell receptor variable-region idiotypeId determinantidiotypic determinant
02

Mechanism of action

Direct binding and neutralization/depletion of B cells expressing the targeted idiotype by anti-idiotype antibodies (via opsonization, ADCC, CDC); Active immunization to elicit anti-idiotype immune responses that recognize and eliminate idiotype-expressing malignant B cells (idiotype vaccination); T cell–mediated responses induced by presentation of idiotype-derived peptides (MHC class II) following B-cell activation, supporting anti-idiotype immunity.

03

Biological functions

Immune response modulation via idiotype/anti-idiotype networksAntigen recognition specificity marker of a B-cell clone (clonotypic marker)Potential antigen for T cells when presented as BCR-derived peptides by B cells (MHC class II–restricted presentation)
04

Disease associations

Cancer (clonal B-cell malignancies where the tumor’s BCR idiotype is a unique, targetable marker; foundation for idiotype vaccines and anti-idiotype antibodies)Infection and autoimmunity (idiotype/anti-idiotype regulation has been implicated in infectious and autoimmune settings through network interactions)Other (general role in immune regulation and memory maintenance via idiotype networks)
05

Safety considerations

Antigen heterogeneity and clonal evolution leading to immune escape (loss/mutation of the idiotype)Individualized manufacturing and scalability challenges for patient-specific idiotype therapeutics (logistical/production complexity)Risk of off-target anti-idiotype network effects and limited immunogenicity requiring adjuvants/carrier proteins
06

Interacting drugs

Anti-idiotype monoclonal antibodies targeting a tumor’s BCR idiotype (concept established in idiotype-based immunotherapy; product names vary by patient-specific idiotype; class-level example: anti-Id antibodies used in B-cell lymphoma vaccine/therapy strategies)

1 more in the full profile.

07

Biomarkers

Tumor-specific BCR rearrangement/idiotype sequence as a clonotypic biomarker for minimal residual disease monitoringPresence/levels of anti-idiotype antibodies or T-cell responses as pharmacodynamic markers in idiotype vaccine/antibody trials

Beyond the preview

Go deeper on B-cell receptor idiotype (Id (idiotype)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on B-cell receptor idiotype (Id (idiotype)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call